JP2018513679A5 - - Google Patents

Download PDF

Info

Publication number
JP2018513679A5
JP2018513679A5 JP2017549623A JP2017549623A JP2018513679A5 JP 2018513679 A5 JP2018513679 A5 JP 2018513679A5 JP 2017549623 A JP2017549623 A JP 2017549623A JP 2017549623 A JP2017549623 A JP 2017549623A JP 2018513679 A5 JP2018513679 A5 JP 2018513679A5
Authority
JP
Japan
Prior art keywords
cancer
cdna
ctcs
droplet
ctc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017549623A
Other languages
English (en)
Japanese (ja)
Other versions
JP7144934B2 (ja
JP2018513679A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/024367 external-priority patent/WO2016154600A1/en
Publication of JP2018513679A publication Critical patent/JP2018513679A/ja
Publication of JP2018513679A5 publication Critical patent/JP2018513679A5/ja
Application granted granted Critical
Publication of JP7144934B2 publication Critical patent/JP7144934B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017549623A 2015-03-25 2016-03-25 血液試料中の循環腫瘍細胞のデジタル分析 Active JP7144934B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562137891P 2015-03-25 2015-03-25
US62/137,891 2015-03-25
US201562219339P 2015-09-16 2015-09-16
US62/219,339 2015-09-16
US201562253619P 2015-11-10 2015-11-10
US62/253,619 2015-11-10
PCT/US2016/024367 WO2016154600A1 (en) 2015-03-25 2016-03-25 Digital analysis of circulating tumor cells in blood samples

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021012116A Division JP7203128B2 (ja) 2015-03-25 2021-01-28 血液試料中の循環腫瘍細胞のデジタル分析

Publications (3)

Publication Number Publication Date
JP2018513679A JP2018513679A (ja) 2018-05-31
JP2018513679A5 true JP2018513679A5 (enExample) 2019-05-09
JP7144934B2 JP7144934B2 (ja) 2022-09-30

Family

ID=56977798

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017549623A Active JP7144934B2 (ja) 2015-03-25 2016-03-25 血液試料中の循環腫瘍細胞のデジタル分析
JP2021012116A Active JP7203128B2 (ja) 2015-03-25 2021-01-28 血液試料中の循環腫瘍細胞のデジタル分析

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021012116A Active JP7203128B2 (ja) 2015-03-25 2021-01-28 血液試料中の循環腫瘍細胞のデジタル分析

Country Status (9)

Country Link
US (3) US20180057889A1 (enExample)
EP (1) EP3274476B1 (enExample)
JP (2) JP7144934B2 (enExample)
KR (1) KR102502087B1 (enExample)
CN (1) CN107614698A (enExample)
AU (2) AU2016238253B2 (enExample)
ES (1) ES2954456T3 (enExample)
IL (1) IL254639B (enExample)
WO (1) WO2016154600A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4361606A3 (en) 2012-02-03 2024-07-10 California Institute of Technology Signal encoding and decoding in multiplexed biochemical assays
US20180057889A1 (en) 2015-03-25 2018-03-01 The General Hospital Corporation Digital Analysis of Circulating Tumor Cells in Blood Samples
CN110050075B (zh) * 2016-10-27 2024-04-02 通用医疗公司 用于确定特定癌症的癌症疗法的功效的血液样品的数字分析
US20180252722A1 (en) * 2017-03-05 2018-09-06 Yan Wang PCR-based Method for Counting Circulating Tumor Cells
US11597963B2 (en) * 2017-11-09 2023-03-07 Biomillenia Sas Microbial selection system
US20200399681A1 (en) * 2018-02-23 2020-12-24 Cornell University Assay for detection of androgen receptor variants
CN108535145A (zh) * 2018-03-09 2018-09-14 深圳市瑞图生物技术有限公司 快速检测外周血液中网织红细胞数量的方法及装置
EP3781710A4 (en) 2018-04-17 2022-01-05 Chromacode, Inc. METHODS AND SYSTEMS FOR MULTIPLEX ANALYSIS
CN110456034B (zh) * 2018-05-07 2022-07-22 上海市第十人民医院 一种循环肿瘤细胞的检测方法
EP3814775A4 (en) 2018-06-29 2021-09-01 The General Hospital Corporation ISOLATION AND ANALYSIS OF CELLS AND RARE PARTICLES DERIVED FROM THE BRAIN
US12203129B2 (en) * 2018-07-03 2025-01-21 ChromaCode, Inc. Formulations and signal encoding and decoding methods for massively multiplexed biochemical assays
JP2022500029A (ja) * 2018-09-11 2022-01-04 ザ ジェネラル ホスピタル コーポレイション 肝臓疾患を検出する方法
KR102380529B1 (ko) * 2020-04-29 2022-03-31 인제대학교 산학협력단 전이성 전립선 암의 진단 및 예후 예측을 위한 혈중종양세포 기반 바이오 마커 조성물
CN112662774A (zh) * 2021-01-12 2021-04-16 南方医科大学南方医院 一种肝癌循环肿瘤细胞标志物及其应用
WO2022187684A1 (en) 2021-03-05 2022-09-09 Enumerix, Inc. Systems and methods for generating droplets and performing digital analyses
US12540948B2 (en) 2021-03-05 2026-02-03 Countable Labs, Inc. Systems and methods for generating droplets and performing digital analyses
CN114395622A (zh) * 2021-12-13 2022-04-26 深圳先进技术研究院 一种利用数字pcr检测循环肿瘤细胞egfr基因突变的方法及其应用
DE102022211089A1 (de) * 2022-10-19 2024-04-25 Robert Bosch Gesellschaft mit beschränkter Haftung Kombinierte Zellspezifische Markierung und Anreicherung von Biomarkern

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8535A (en) 1851-11-18 Stove-geate
US889A (en) 1838-08-20 Mode of constructing metal bench-vises
DE29623597U1 (de) 1996-11-08 1999-01-07 Eppendorf - Netheler - Hinz Gmbh, 22339 Hamburg Temperierblock mit Temperiereinrichtungen
US20080050393A1 (en) 1998-12-03 2008-02-28 Tang Y Tom Novel nucleic acids and polypeptides
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
AU2001280982A1 (en) * 2000-08-03 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20030143539A1 (en) 2000-12-08 2003-07-31 Francois Bertucci Gene expression profiling of primary breast carcinomas using arrays of candidate genes
US20030064385A1 (en) 2001-05-16 2003-04-03 Dressman Marlene Michelle Genes expressed in breast cancer as prognostic and therapeutic targets
US20030073623A1 (en) 2001-07-30 2003-04-17 Drmanac Radoje T. Novel nucleic acid sequences obtained from various cDNA libraries
US20040142325A1 (en) 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US20060275794A1 (en) 2005-03-07 2006-12-07 Invitrogen Corporation Collections of matched biological reagents and methods for identifying matched reagents
US20070026417A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
WO2006121991A2 (en) 2005-05-06 2006-11-16 Diadexus, Inc. Compositions and methods for detection, prognosis and treatment of breast cancer
CN101365950B (zh) * 2005-09-19 2015-11-25 维里德克斯有限责任公司 用于鉴别原发起源不明癌的起源的方法和材料
US20090275486A1 (en) * 2006-05-16 2009-11-05 Nurith Kurn Nucleic acid separation and purification method based on reversible charge interactions
US8372584B2 (en) * 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
WO2009051734A1 (en) 2007-10-17 2009-04-23 The General Hospital Corporation Microchip-based devices for capturing circulating tumor cells and methods of their use
US9068181B2 (en) 2008-05-23 2015-06-30 The General Hospital Corporation Microfluidic droplet encapsulation
US20120252015A1 (en) * 2011-02-18 2012-10-04 Bio-Rad Laboratories Methods and compositions for detecting genetic material
US9625454B2 (en) * 2009-09-04 2017-04-18 The Research Foundation For The State University Of New York Rapid and continuous analyte processing in droplet microfluidic devices
US20110166030A1 (en) * 2009-09-30 2011-07-07 Yixin Wang Prediction of response to docetaxel therapy based on the presence of TMPRSSG2:ERG fusion in circulating tumor cells
EP4435111A1 (en) 2010-02-12 2024-09-25 Bio-Rad Laboratories, Inc. Digital analyte analysis
WO2011112903A2 (en) 2010-03-11 2011-09-15 Board Of Regents, The University Of Texas System Quantitative rt-pcr detection for genes involved in epithelial mesenchymal transition in peripheral blood of breast cancer patients
EP2553118B1 (en) 2010-03-31 2014-10-15 Sividon Diagnostics GmbH Method for breast cancer recurrence prediction under endocrine treatment
AU2015268617A1 (en) 2010-03-31 2016-01-07 Sividon Diagnostics Gmbh Method for breast cancer recurrence prediction under endocrine treatment
US9650629B2 (en) * 2010-07-07 2017-05-16 Roche Molecular Systems, Inc. Clonal pre-amplification in emulsion
WO2012024543A1 (en) 2010-08-18 2012-02-23 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
JP2014507160A (ja) 2011-02-22 2014-03-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． 循環バイオマーカー
WO2012135397A2 (en) 2011-03-29 2012-10-04 Lisanti Michael P Lactate-and ketones-induced gene signatures and use the same for diagnosing disease and predicting clinical outcome
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US20140287956A1 (en) * 2011-10-24 2014-09-25 The General Hospital Corporation Biomarkers of Cancer
US9766244B2 (en) 2012-07-02 2017-09-19 The General Hospital Corporation Diagnosis and monitoring treatment of prostate cancer
WO2014028378A2 (en) * 2012-08-13 2014-02-20 The Regents Of The University Of California Methods and systems for detecting biological components
US10113200B2 (en) 2012-09-14 2018-10-30 Memorial Sloan-Kettering Cancer Center Genes associated with dasatinib sensitivity
WO2014047285A1 (en) 2012-09-19 2014-03-27 Paraskevi Giannakakou Identifying taxane sensitivity in prostate cancer patients
WO2014075067A1 (en) 2012-11-12 2014-05-15 Nanostring Technologies, Inc. Methods to predict breast cancer outcome
WO2014165762A1 (en) 2013-04-05 2014-10-09 Raindance Technologies, Inc. Rare cell analysis after negative selection
KR20160058774A (ko) 2013-08-12 2016-05-25 토카이 파마슈티컬, 아이엔씨. 안드로겐-표적 치료제를 이용하는 종양 질환 치료를 위한 바이오마커
EP3560591B1 (en) 2013-10-18 2021-02-17 The General Hospital Corporation Microfluidic sorting using high gradient magnetic fields
MA39740A (fr) 2014-03-13 2017-01-18 Hoffmann La Roche Méthodes et compositions pour moduler des mutants du récepteur des oestrogènes
RU2016148441A (ru) 2014-05-21 2018-06-22 Ф. Хоффманн-Ля Рош Аг Способ лечения pr-положительного люминального а-типа рака молочной железы ингибитором pi3k пиктилисибом
EP3699589A1 (en) 2014-12-12 2020-08-26 Celcuity Inc. Methods of measuring erbb signaling pathway activity to diagnose and treat cancer patients
EP3259375B1 (en) 2015-02-20 2019-01-09 Comelz S.p.a. Method for cutting natural hides
SMT202200062T1 (it) 2015-03-12 2022-03-21 Janssen Pharmaceutica Nv Marcatori di mrna a base di sangue intero per la previsione del cancro della prostata e metodi di rilevazione degli stessi
US20180057889A1 (en) 2015-03-25 2018-03-01 The General Hospital Corporation Digital Analysis of Circulating Tumor Cells in Blood Samples
CN110050075B (zh) 2016-10-27 2024-04-02 通用医疗公司 用于确定特定癌症的癌症疗法的功效的血液样品的数字分析

Similar Documents

Publication Publication Date Title
Heredia-Soto et al. Liquid biopsy in pancreatic cancer: are we ready to apply it in the clinical practice?
Oshi et al. Urine as a source of liquid biopsy for cancer
Johansson et al. Considerations and quality controls when analyzing cell-free tumor DNA
Pardini et al. Noncoding RNAs in extracellular fluids as cancer biomarkers: the new frontier of liquid biopsies
Wan et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA
Daniel et al. A panel of MicroRNAs as diagnostic biomarkers for the identification of prostate cancer
Martinez-Dominguez et al. Current technologies for RNA-directed liquid diagnostics
Pixberg et al. Characterization of DNA methylation in circulating tumor cells
Kolenda et al. cfRNAs as biomarkers in oncology–still experimental or applied tool for personalized medicine already?
JP2014516543A5 (enExample)
US20150184248A1 (en) Method for detecting pancreatic cancer and detection kit
Munteanu et al. MiRNA-based inspired approach in diagnosis of prostate cancer
US10738360B2 (en) Method for assisting detection of alzheimer'S disease or mild cognitive impairment
Temilola et al. The prospect and challenges to the flow of liquid biopsy in Africa
Kim et al. Non-coding RNAs: functional aspects and diagnostic utility in oncology
Kan et al. Exploring the role of circulating cell-free RNA in the development of colorectal cancer
JP2020501517A5 (enExample)
Sorbini et al. Technical advances in circulating cell-free DNA detection and analysis for personalized medicine in patients’ care
Hofmann et al. Telomere length varies by DNA extraction method: implications for epidemiologic research
Rodriguez et al. Non-coding RNA signatures of B-cell acute lymphoblastic leukemia
Crocetto et al. Unlocking precision medicine: liquid biopsy advancements in renal cancer detection and monitoring
Chung et al. Recent technologies towards diagnostic and therapeutic applications of circulating nucleic acids in colorectal cancers
Keup et al. Multimodal targeted deep sequencing of circulating tumor cells and matched cell-free DNA provides a more comprehensive tool to identify therapeutic targets in metastatic breast cancer patients
Ziranu et al. Navigating the landscape of liquid biopsy in colorectal cancer: current insights and future directions
Juracek et al. Urinary microRNAs and their significance in prostate cancer diagnosis: a 5-year update